ABBV vs. WST: AbbVie vs. West Pharmaceutical Services Stock Comparison

June 13, 2026

This page compares AbbVie (ABBV) with West Pharmaceutical Services (WST) using performance and risk, profitability, financial strength, growth, dividends, and valuation metrics.

Performance

Cumulative Growth

ABBV

WST

AbbVie (ABBV) vs. West Pharmaceutical Services (WST): Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for AbbVie (ABBV) and West Pharmaceutical Services (WST). Returns over one year are annualized.

Performance at a Glance

Performance metrics for AbbVie (ABBV) and West Pharmaceutical Services (WST)
Metric	ABBV	WST
1-Year Return	22.21%	46.68%

Risk

Drawdown

ABBV

WST

AbbVie (ABBV) vs. West Pharmaceutical Services (WST): Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Risk at a Glance

Risk metrics for AbbVie (ABBV) and West Pharmaceutical Services (WST)
Metric	ABBV	WST
1-Year Volatility	24.36%	41.40%
Beta	0.31	1.17
3-Month Avg. Volume	6.43M	852.79K

Company Profile

AbbVie (ABBV) and West Pharmaceutical Services (WST) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but ABBV is classified in Biotechnology while WST is classified in Life Sciences Tools & Services.

Company profile comparison for AbbVie (ABBV) and West Pharmaceutical Services (WST)
Profile Item	ABBV	WST
Name	AbbVie Inc.	West Pharmaceutical Services, Inc.
Country/Region	United States	United States
GICS Sector	Health Care	Health Care
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences	Pharmaceuticals, Biotechnology & Life Sciences
GICS Industry	Biotechnology	Life Sciences Tools & Services
GICS Sub-Industry	Biotechnology	Life Sciences Tools & Services
Market Capitalization	402.35 billion USD	23.23 billion USD
Currency	USD	USD
Exchange	NYSE	NYSE
Listing Date	January 2, 2013	March 17, 1980
Security Type	Common Stock	Common Stock

Valuation

Price-to-Earnings Ratio (TTM)

Both look expensive on trailing earnings: West Pharmaceutical Services (WST) at 44.08 sits in the richer P/E ratio quartile, and AbbVie (ABBV) at 111.09 is richer still, above its industry range.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

111.09

ABBV: 111.09
Max: 77.14
Q3: 43.78
Median: 24.68
Q1: 15.27
Min: 1.70

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

44.08

Max: 77.14
WST: 44.08
Q3: 43.78
Median: 24.68
Q1: 15.27
Min: 1.70

AbbVie (ABBV) vs. West Pharmaceutical Services (WST): A comparison of their P/E ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Price-to-Sales Ratio (TTM)

On P/S ratio, both AbbVie (ABBV) at 6.40 and West Pharmaceutical Services (WST) at 7.21 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.40

Max: 55.38
Q3: 24.42
Median: 6.98
ABBV: 6.40
Q1: 3.30
Min: 0.01

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.21

Max: 55.38
Q3: 24.42
WST: 7.21
Median: 6.98
Q1: 3.30
Min: 0.01

AbbVie (ABBV) vs. West Pharmaceutical Services (WST): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Price-to-Book Ratio (MRQ)

AbbVie (ABBV) reports a negative P/B ratio of -60.45, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile West Pharmaceutical Services (WST) reports 7.80, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

-60.45

Max: 13.23
Q3: 6.38
Median: 3.46
Q1: 1.64
Min: -5.17
ABBV: -60.45

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.80

Max: 13.23
WST: 7.80
Q3: 6.38
Median: 3.46
Q1: 1.64
Min: -5.17

AbbVie (ABBV) vs. West Pharmaceutical Services (WST): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation at a Glance

Valuation metrics for AbbVie (ABBV) and West Pharmaceutical Services (WST)
Metric	ABBV	WST
Price-to-Earnings Ratio (TTM)	111.09	44.08
Price-to-Sales Ratio (TTM)	6.40	7.21
Price-to-Book Ratio (MRQ)	-60.45	7.80
Free Cash Flow Yield	5.17%	1.19%

Profitability

Return on Equity (TTM)

Capital efficiency shows on one side only: West Pharmaceutical Services (WST) earns 19.13% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

Max: 101.32%
Q3: 2.92%
Median: -31.26%
Q1: -62.68%
Min: -158.89%
ABBV: --

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

19.13%

Max: 101.32%
WST: 19.13%
Q3: 2.92%
Median: -31.26%
Q1: -62.68%
Min: -158.89%

AbbVie (ABBV) vs. West Pharmaceutical Services (WST): ABBV does not report ROE, so it has no value marker; WST is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Net Profit Margin (TTM)

West Pharmaceutical Services (WST) at 16.85% keeps the most of each sales dollar — above its industry’s net margin range — and AbbVie (ABBV) at 5.79% also retains a top-quartile share.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.79%

Max: 12.76%
ABBV: 5.79%
Q3: 4.00%
Median: 0.00%
Q1: -2.26%
Min: -11.53%

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

16.85%

WST: 16.85%
Max: 12.76%
Q3: 4.00%
Median: 0.00%
Q1: -2.26%
Min: -11.53%

AbbVie (ABBV) vs. West Pharmaceutical Services (WST): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Profit Margin (TTM)

Both AbbVie (ABBV) at 32.16% and West Pharmaceutical Services (WST) at 21.70% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

32.16%

Max: 100.30%
ABBV: 32.16%
Q3: 4.40%
Median: 0.00%
Q1: -131.52%
Min: -333.43%

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

21.70%

Max: 100.30%
WST: 21.70%
Q3: 4.40%
Median: 0.00%
Q1: -131.52%
Min: -333.43%

AbbVie (ABBV) vs. West Pharmaceutical Services (WST): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability at a Glance

Profitability metrics for AbbVie (ABBV) and West Pharmaceutical Services (WST)
Metric	ABBV	WST
Return on Equity (TTM)	--	19.13%
Return on Assets (TTM)	10.03%	11.21%
Net Profit Margin (TTM)	5.79%	16.85%
Operating Profit Margin (TTM)	32.16%	21.70%
Gross Profit Margin (TTM)	72.03%	36.28%

Growth

Revenue Growth

AbbVie (ABBV) vs. West Pharmaceutical Services (WST): A comparison of their Revenue Growth across different time periods.

Revenue Growth at a Glance

Revenue growth metrics for AbbVie (ABBV) and West Pharmaceutical Services (WST)
Metric	ABBV	WST
1-Year Revenue Growth	8.57%	6.25%
3-Year Revenue CAGR	1.75%	2.12%

EPS Growth

AbbVie (ABBV) vs. West Pharmaceutical Services (WST): A comparison of their EPS Growth across different time periods.

EPS Growth at a Glance

EPS growth metrics for AbbVie (ABBV) and West Pharmaceutical Services (WST)
Metric	ABBV	WST
1-Year EPS Growth	-1.26%	1.49%
3-Year EPS CAGR	-29.13%	-4.23%

Financial Strength

Current Ratio (MRQ)

West Pharmaceutical Services (WST) at 2.71 keeps current ratio within its industry’s typical mid-range, while AbbVie (ABBV) at 0.80 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for ABBV.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.80

Max: 24.81
Q3: 11.75
Median: 5.57
Q1: 2.69
ABBV: 0.80
Min: 0.23

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.71

Max: 24.81
Q3: 11.75
Median: 5.57
WST: 2.71
Q1: 2.69
Min: 0.23

AbbVie (ABBV) vs. West Pharmaceutical Services (WST): A comparison of their current ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Debt-to-Equity Ratio (MRQ)

Only one side’s leverage can be read here: West Pharmaceutical Services (WST) carries debt-to-equity ratio of 0.11 against its industry range, while AbbVie (ABBV) reports no figure this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

Max: 1.60
Q3: 0.68
Median: 0.15
Q1: 0.02
Min: 0.00
ABBV: --

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.11

Max: 1.60
Q3: 0.68
Median: 0.15
WST: 0.11
Q1: 0.02
Min: 0.00

AbbVie (ABBV) vs. West Pharmaceutical Services (WST): ABBV does not report debt-to-equity ratio, so it has no value marker; WST is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Financial Strength at a Glance

Financial strength metrics for AbbVie (ABBV) and West Pharmaceutical Services (WST)
Metric	ABBV	WST
Current Ratio (MRQ)	0.80	2.71
Debt-to-Equity Ratio (MRQ)	--	0.11
Net Debt / EBITDA	2.12	-0.23

Dividends

Dividend Yield (TTM)

Both AbbVie (ABBV) at 3.04% and West Pharmaceutical Services (WST) at 0.27% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

3.04%

ABBV: 3.04%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.27%

WST: 0.27%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

AbbVie (ABBV) vs. West Pharmaceutical Services (WST): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

AbbVie (ABBV) reports payout ratio above 100% at 325.98%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile West Pharmaceutical Services (WST) reports 11.50%, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

325.98%

ABBV: 325.98%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

11.50%

WST: 11.50%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

AbbVie (ABBV) vs. West Pharmaceutical Services (WST): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividends at a Glance

Dividend metrics for AbbVie (ABBV) and West Pharmaceutical Services (WST)
Metric	ABBV	WST
Dividend Yield (TTM)	3.04%	0.27%
Dividend Payout Ratio (TTM)	325.98%	11.50%